News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zen-Bio, Inc. Awarded Grant to Provide Human Breast Cancer Cell System


9/16/2008 1:53:41 PM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--ZenBio, Inc., a privately held biotechnology company, announced that it has been awarded a Phase I SBIR grant to provide a unique human primary cell system for breast cancer research. The $200,000 award from the National Institutes of Health will fund the isolation and culturing of primary human basal and luminal mammary ductal cells for the development of a donor-matched cell system.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES